Autres langues Kwality Pharmaceuticals Limited

Actions

KPL

INE552U01010

Produits pharmaceutiques

Temps Différé Bombay S.E. 09:50:50 18/09/2026			Varia. 5j.	Varia. 1 janv.
3 475,00 ^INR	+0,69%		-4,60%	+213,53%

02/09	Kwality Pharmaceuticals Limited nomme Swanith Kapoor au poste de administrateur indépendant non exécutif, avec effet au 02 juin 2026	CI
10/08	Kwality Pharmaceuticals Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI

Autres langues

02/09	Kwality Pharmaceuticals Limited Appoints Swanith Kapoor, as the Non-Executive Independent Director, Effective 02 June, 2026
10/08	Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
02/06	Kwality Pharmaceuticals Limited Announces Resignation of Kartik Kapur as Independent Director, Effective June 02, 2026
19/05	Kwality Pharmaceuticals' Consolidated Profit Rises in Fiscal Q4; Shares Jump 9%
19/05	Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027
19/05	Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
11/03	Chatha Foods Limited Announces Change in Designation of Mrs. Rachna Singh Chaudhary as Chief Human Resource Officer, Effective March 11, 2026
10/03	Kwality Pharmaceuticals completes phase 1 BE studies for three molecules
12/02	Kwality Pharmaceuticals' Consolidated Profit Jumps in Fiscal Q3; Shares Surge 16%
12/02	Kwality Pharmaceuticals Ltd Dec-quarter consol net profit 160.1 million rupees
12/02	Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
02/02	Kwality Pharmaceuticals Limited Announces Completion of Term of Pankaj Takkar and Ravi Shanker as Independent Directors and from Committees Membership and Chairmanship, Effective January 31, 2026
13/11	Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
13/11	Kwality Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q2; Shares Up 7%
13/11	Kwality pharmaceuticals sept-qtr consol net profit 141.2 mln rupees
06/11	Kwality Pharmaceuticals Gets No Major Observations After EU-GMP Audit
11/09/25	Kwality Pharmaceuticals Limited Approves Appointment of Vinod Kumar Sharma as Independent Director
18/08/25	Kwality Pharmaceuticals Gets Registration to Sell 'Bleomycin 15 1U' in Mexico ; Down 3%
11/08/25	Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
11/08/25	Kwality Pharmaceuticals June-quarter consol net profit 119.3 million rupees
26/07/25	Kwality Pharmaceuticals Limited Announces Resignation of Kiran Kumar Verma as an Independent Director, Effective July 26, 2025
19/05/25	Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Financial Year 2026
19/05/25	Kwality Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2025
07/05/25	Kwality Pharmaceuticals Concludes Regulatory Audit for Zimbabwe; Shares Down 4%
26/11/24	Kwality Pharmaceuticals Secures Approval to Manufacture, Sell PEGylated - Asparaginase